Butterfly Network (BFLY) Liabilities and Shareholders Equity (2020 - 2026)

Butterfly Network (BFLY) reported Liabilities and Shareholders Equity of $285.9 million for Q1 2026, down 10.2% on a YoY basis from $318.4 million in Q1 2025, and down 3.58% sequentially from $296.5 million in Q4 2025.

Butterfly Network (BFLY) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Butterfly Network (BFLY) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $285.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 10.2% year-over-year to $285.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (up 6.55% YoY), and the FY2025 full-year result was $296.5 million, up 15.8% from the prior year.
  • Liabilities and Shareholders Equity retreated to $285.9 million in Q1 2026, from $296.5 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $535.4 million in Q1 2022 to a low of $256.1 million in Q4 2024.
  • A 5-year average of $344.7 million and a median of $313.3 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity dropped 28.71% in 2023 and rose 15.8% in 2025, its largest moves.
  • Tracing BFLY's Liabilities and Shareholders Equity over 5 years: stood at $417.6 million in 2022, then retreated by 27.13% to $304.3 million in 2023, then slipped by 15.84% to $256.1 million in 2024, then gained by 15.8% to $296.5 million in 2025, then fell by 3.58% to $285.9 million in 2026.
  • Business Quant data shows BFLY's Liabilities and Shareholders Equity at $285.9 million in Q1 2026, $296.5 million in Q4 2025, and $290.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 184.26 Bn 176.96 Bn 6.27 Bn 110.43 Bn
2 Stryker 128.82 Bn 125.94 Bn 3.81 Bn 46.29 Bn
3 Medtronic 108.86 Bn 99.64 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 68.54 Bn 67.09 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 47.53 Bn 43.86 Bn 1.29 Bn 13.32 Bn
6 GE HealthCare Technologies 28.45 Bn 26.17 Bn 1.98 Bn 37.13 Bn
7 Dexcom 28.43 Bn 27.31 Bn 750.30 Mn 6.63 Bn
8 Smith & Nephew 26.96 Bn 26.39 Bn - 10.46 Bn
9 Koninklijke Philips 25.53 Bn 22.41 Bn 2.07 Bn 31.92 Bn
10 Butterfly Network 1.77 Bn 1.63 Bn 18.29 Mn 285.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 285.92 Mn
Dec 31, 2025 296.53 Mn
Sep 30, 2025 290.00 Mn
Jun 30, 2025 313.28 Mn
Mar 31, 2025 318.41 Mn
Dec 31, 2024 256.08 Mn
Sep 30, 2024 265.27 Mn
Jun 30, 2024 273.07 Mn
Mar 31, 2024 284.29 Mn
Dec 31, 2023 304.27 Mn
Sep 30, 2023 334.22 Mn
Jun 30, 2023 364.59 Mn
Mar 31, 2023 381.68 Mn
Dec 31, 2022 417.57 Mn
Sep 30, 2022 443.26 Mn
Jun 30, 2022 496.64 Mn
Mar 31, 2022 535.42 Mn
Dec 31, 2021 571.97 Mn
Sep 30, 2021 580.32 Mn
Jun 30, 2021 631.26 Mn